News Image

Tuesday's pre-market session: top gainers and losers

By Mill Chart

Last update: Sep 27, 2022

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Pre-market gainers

TickerChangeComment
KPRX4.0K%KIORA PHARMACEUTICALS INC's (NASDAQ:KPRX) stock price increased by 4.0K% to $6.55. NASDAQ:KPRX seems to be recovering from a -10.05% loss in the previous session.
IONM28.03%ASSURE HOLDINGS CORP's (NASDAQ:IONM) shares rose 28.03% to $0.72. The stock is trading 43.77% lower than a month ago.
SXTC25.58%CHINA SXT PHARMACEUTICALS IN's (NASDAQ:SXTC) stock price is advancing with 25.58% to a price of $1.08. In the last month the share price dropped with 39.01%.
ILAG24.51%INTELLIGENT LIVING APPLICATI (NASDAQ:ILAG) rose 24.51% to $2.54 during Tuesday's pre-market session. Also in the previous session NASDAQ:ILAG had a very good day: shares closed with a 11.48% gain.
NMTR21.98%9 METERS BIOPHARMA INC's (NASDAQ:NMTR) shares rose 21.98% to $0.25 during Tuesday's pre-market session. The stock is trading 31.02% lower than a month ago.
AVCTW20.0%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) shares rose 20.0% to $0.08. In the last month the share price increased with 56.25%.
BTB19.2%BIT BROTHER LTD's (NASDAQ:BTB) stock price is advancing with 19.2% to a price of $0.15. Prices are quite volatile here as yesterday NASDAQ:BTB closed with a -12.46% loss.
AYLA19.05%AYALA PHARMACEUTICALS INC's (NASDAQ:AYLA) stock price is advancing with 19.05% to a price of $1.25. The stock is trading 36.75% lower than a month ago.
MF17.98%MISSFRESH LTD-ADR's (NASDAQ:MF) stock price is advancing with 17.98% to a price of $0.1. Shareholders saw the stock price going 34.32% lower in the past month.
STIM15.2%NEURONETICS INC's (NASDAQ:STIM) stock price increased by 15.2% to $2.72. Shareholders saw the stock price going 43.13% lower in the past month.

Our premarket gainers screener will show you the full list.

Pre-market losers

TickerChangeComment
ARDS-34.14%ARIDIS PHARMACEUTICALS INC's (NASDAQ:ARDS) stock price decreased by 34.14% to $0.56. Yesterday's drop of -29.73% continued in today's pre-market session with another decline of 34.14%
RNA-24.32%AVIDITY BIOSCIENCES INC's (NASDAQ:RNA) stock price decreased by 24.32% to $14.19. Shareholders saw the stock price going 21.28% higher in the past 3 months.
AMST-13.41%AMESITE INC's (NASDAQ:AMST) stock price is declining with 13.41% to a price of $0.25. Shareholders saw the stock price going 61.84% lower in the past month.
FNHC-9.13%FEDNAT HOLDING CO's (NASDAQ:FNHC) stock price is declining with 9.13% to a price of $0.2. NASDAQ:FNHC already had a hard day yesterday: closing -15.86% lower during the regular session.
LAUR-8.91%LAUREATE EDUCATION INC's (NASDAQ:LAUR) shares fell 8.91% to $10.02. Shareholders saw the stock price going 38.85% lower is the past year.
PFLT-7.79%PENNANTPARK FLOATING RATE CA's (NYSE:PFLT) stock price decreased by 7.79% to $9.0. The stock is trading 20.39% lower than a month ago.
AKTX-7.1%AKARI THERAPEUTICS PLC-ADR's (NASDAQ:AKTX) stock price decreased by 7.1% to $0.51. The stock is trading 53.87% lower than a month ago.
NVIV-6.99%INVIVO THERAPEUTICS HOLDINGS's (NASDAQ:NVIV) stock price decreased by 6.99% to $3.86. Shareholders saw the stock price going 41.34% lower in the past month.
MTP-6.92%MIDATECH PHARMA PLC-ADR's (NASDAQ:MTP) stock price is declining with 6.92% to a price of $2.42. After yesterdays gain of 373.0%, it goes down with 6.92% in today's pre-market session.
KXIN-6.73%KAIXIN AUTO HOLDINGS's (NASDAQ:KXIN) stock price is declining with 6.73% to a price of $0.91. In the last month the share price increased with 23.66%.

Our premarket losers screener will show you the full list.

Back

NEURONETICS INC

NASDAQ:STIM (4/24/2024, 1:05:57 PM)

3.735

-0.12 (-3.24%)

STIM News

News Image22 hours ago - NeuroneticsNeuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and...

News Image14 days ago - NeuroneticsNew Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

Lack of early symptom improvement is not predictive of final responder status

News Image14 days ago - NeuroneticsNew Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

Lack of early symptom improvement is not predictive of final responder status...

News Imagea month ago - NeuroneticsNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Imagea month ago - NeuroneticsNeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older

News Imagea month ago - NeuroneticsNeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older...

News Image2 months ago - NeuroneticsNeuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
News Image2 months ago - NeuroneticsNeuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and...

News Image2 months ago - NeuroneticsNeuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results

MALVERN, Pa., March 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology...

News Image2 months ago - NeuroneticsNeuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release fourth quarter 2023 financial and operating results prior to market open on Tuesday, March 5th, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

News Image2 months ago - NeuroneticsNeuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

Advancements provide workflow efficiencies for NeuroStar® TMS providers

News Image2 months ago - NeuroneticsNeuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

Advancements provide workflow efficiencies for NeuroStar® TMS providers...

STIM Links
Follow us for more